LeonaBio, Inc.
LONA
$7.04
-$0.98-12.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.58M | 6.88M | 3.77M | 4.05M | 3.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.28M | 18.14M | 10.48M | 6.87M | 7.29M |
| Operating Income | -19.28M | -18.14M | -10.48M | -6.87M | -7.29M |
| Income Before Tax | -19.01M | -32.95M | -82.89M | -6.61M | -6.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.01M | -32.95M | -82.89M | -6.61M | -6.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.01M | -32.95M | -82.89M | -6.61M | -6.97M |
| EBIT | -19.28M | -18.14M | -10.48M | -6.87M | -7.29M |
| EBITDA | -19.05M | -17.91M | -10.23M | -6.63M | -7.05M |
| EPS Basic | -0.80 | -1.73 | -15.51 | -1.68 | -1.78 |
| Normalized Basic EPS | -0.50 | -1.09 | -1.74 | -1.05 | -1.11 |
| EPS Diluted | -0.80 | -1.73 | -15.51 | -1.68 | -1.78 |
| Normalized Diluted EPS | -0.50 | -1.09 | -1.74 | -1.05 | -1.11 |
| Average Basic Shares Outstanding | 23.73M | 19.03M | 5.35M | 3.94M | 3.91M |
| Average Diluted Shares Outstanding | 23.73M | 19.03M | 5.35M | 3.94M | 3.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |